Novavax (NVAX.US) reported for this quarter no expected revenue, thanks to a grant from the US government for clinical studies. Despite the mid-term drop in revenue from USD 734.58 million to USD 187 million, the company is working to optimize these grants. In order to deal with the growing market for COVID-19 vaccines, Novavax has not waited, it has sunk its bonds and is preparing for a dream investment of another $300 million in 2024.
It is estimated that the US market for COVID-19 vaccines will demand 30 and 50 million doses in the 2023-2024 season. They revealed that no more than 15 million people in the US have received the updated COVID-19 vaccine, which is behind the vaccine from the previous year.
Novavax secured year-end access to its COVID-19 vaccine in US hospitals and received approval for its updated vaccine. The company has significantly reduced its costs, reduced operating costs by 47% compared to the previous year, and is well on its way to fulfilling its full global restructuring and cost reduction. In the future, Novavax will focus on the initial investment of the program, its goal is no more than 300 million dollars in 2024, financial stability and progress in vaccine technology.
From a technical point of view, the price of Novavax is on the chart (NVAX.US) since the start of this year in the boom channel and has ranged between $6.20 per share and $10.20 per share. Compared to the year 20221, shares are trading up to -98%. Today, after the results, the stock rose by 1.40% before the market opened. Source xStation 5.
X-Trade Brokers (XTB) is an international brokerage house that provides professional conditions for trading CFDs on forex, indices, commodities, cryptocurrencies and for investing in shares and ETFs. He is constantly improving his services, which is evidenced by a number of international awards and this is also confirmed by the domestic award of Broker of the Year and Forex Broker of the Year, which was repeated at the MoneyExpo Investment Summit. For its clients, XTB offers professional trading platforms MetaTrader 4 and xStation 5 with an integrated calculator, free extension, 24-hour customer support, free extension and daily news from the financial markets.
The distribution of contracts are complex instruments and due to the use of financial leverage, they are associated with a high risk of rapid financial loss. In the case of 72% of the retail investors, the trading with installment contracts with this provider resulted in a loss. You should make sure you understand how the installment contract works and whether you can afford the high risk of losing your funds.